AVP and congestive heart failure: An exaggerated increase in circulatory plasma volume is linked to organ disorders such as congestive heart failure, decompensated liver cirrhosis and nephrotic syndrome, in which non-osmotic release of arginine vasopressin (AVP) is associated with an increase in water permeability in cells of the renal collecting duct [1,2].